All In Biotech

Free tool

FAERS Monitor: Amzeeq

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 212379 or its brand name (Amzeeq, Minocycline Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

11,701

Serious

8,940

76% of reports

Hospitalization

3,776

Death reported

1,645

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,981
  • off label use1,488
  • nausea1,077
  • pain1,021
  • arthralgia1,003
  • fatigue962
  • drug intolerance913
  • rash910
  • drug hypersensitivity907
  • rheumatoid arthritis879
  • joint swelling874
  • headache804
  • condition aggravated754
  • diarrhoea752
  • pneumonia750

Reports by year received

View as table
YearReports
200411
200552
20067
20072
20086
200979
201086
201199
2012233
2013416
2014431
2015539
2016806
2017871
2018894
20191,144
20201,038
2021780
2022704
2023882
20241,205
2025974
2026442

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,458 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug intoleranceSignal91317.116.113,793
rheumatoid arthritisSignal87914.013.210,589
joint swellingSignal87413.112.39,744
drug hypersensitivitySignal9078.57.95,986
condition aggravatedSignal7544.54.22,050
arthralgiaSignal1,0034.34.12,624
pneumoniaSignal7504.23.91,829
rashSignal9103.83.51,874
off label useSignal1,4883.12.92,145
painSignal1,0213.02.81,390
drug ineffectiveSignal1,9812.72.62,265
nauseaSignal1,0772.42.3956
headacheSignal8042.32.2611
fatigueSignal9622.22.1670
diarrhoeaSignal7522.12.0443

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.